The use of intravenous albumin in decongestion of acutely decompensated heart failure-diorasis trial, early outcomes

13 May 2024 (15:51 - 17:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Marios Vasileios Koutroulos

General University Hospital of Alexandroupolis, Alexandroupolis (Greece)

6 More presentations in this session

Presentation thumbnail

Challenging the norm: the use of sublingual nitroglycerin in patients with severe aortic stenosis undergoing cardiac CT

Doctor A. Silva (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Age differences in prescribing guideline-directed medical treatment in heart failure with mildly reduced and reduced ejection fraction

Doctor V. Lopes (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital

Doctor M. Assamti (Oujda, MA)

Abstract Slides Video

Presentation thumbnail

Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function

Doctor A. Amanova (Aktobe, KZ)

Abstract Slides Video

Presentation thumbnail

Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

Doctor V. De Simone (Legnago, IT)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in interventional cardiology and pharmacology 2

The Event

Event poster

Heart Failure 2024

13 May 2024 15:51 CET

You may be interested in

Congress Presentation

Diuresis efficacy in ambulatory congested heart failure patients: Intra -patient comparison of three diuretic regimens (DEA-HF)

Congress Presentation

Efficacy of hypertonic saline therapy in ambulatory patients with heart failure

Congress Presentation

DEA-HF: The heart failure diuresis efficacy comparison study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources